Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 23.01
-0.26 (-1.12%)
Mar 26, 2026, 11:15 AM CST
SHA:600332 Revenue
In the year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B CNY with 3.55% growth. Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 16.05B in the quarter ending December 31, 2025, with 0.74% growth.
Revenue
77.66B
Revenue Growth
+3.55%
P/S Ratio
0.46
Revenue / Employee
2.87M
Employees
27,425
Market Cap
36.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.66B | 2.66B | 3.55% |
| Dec 31, 2024 | 74.99B | -522.58M | -0.69% |
| Dec 31, 2023 | 75.52B | 4.73B | 6.68% |
| Dec 31, 2022 | 70.79B | 1.77B | 2.57% |
| Dec 31, 2021 | 69.01B | 7.34B | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| China National Accord Medicines Corporation | 73.42B |
| China National Medicines Corporation | 52.47B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |